在肝硬化和肥胖患者中优化肝移植候选人
Nghiem B Ha1, Julie K Heimbach2, Bilal Hameed1
1Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
概括
肝移植候选人的肥胖症正在增加,与代谢功能障碍相关的脂肪性肝病 (MASLD) 是移植的常见原因. 本综述探讨了最佳的手术和医疗肥胖管理策略,以改善长期肝移植结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
- 减肥医学 减肥医学
背景情况:
- 美国肥胖率上升对肝移植人口产生影响.
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是肝移植的主要适应症.
- 肝移植患者的最佳肥胖管理策略尚未得到充分定义.
研究的目的:
- 审查目前关于肝移植候选人的手术肥胖管理的证据.
- 讨论新型的医学疗法对肥胖在这个人群.
- 引导最佳的移植前,移植前和移植后肥胖管理,以改善患者的治疗结果.
主要方法:
- 关于手术和医学肥胖治疗的综合文献综述.
- 分析有关干预时间和有效性的证据.
- 讨论肝移植患者肥胖的综合护理策略.
主要成果:
- 提出了手术管理和最佳时机的证据.
- 审查了针对肥胖的新型医学疗法.
- 讨论了将这些治疗方法整合到移植护理中的策略.
结论:
- 优化肥胖管理对于肝移植成功至关重要.
- 可能需要一种多学科的方法,将手术和医疗干预相结合.
- 需要进一步的研究,以建立确切的指导方针,用于肝移植接受者的肥胖管理.
相关概念视频
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


